Publications by authors named "Thomas Waldmann"

Claim this Profile
F
From small batteries to big claims.
Rares-George Scurtu, Alessandro Innocenti, Vanessa Scheck, Mario Maunz, Thomas Waldmann

Nat Nanotechnol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies.
Max J Gordon, Sigrid Dubois, Milos D Miljkovic, Samuel Ng, Bonita Bryant, Thomas Waldmann

Blood Neoplasia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
Max J Gordon, Sigrid Dubois, Bonita Bryant, Samuel Ng, Kevin Conlon, Thomas Waldmann

Leuk Lymphoma· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma.
Yunxia Liu, Shuichi Kimpara, Nguyet M Hoang, Anusara Daenthanasanmak, Yangguang Li, Thomas A Waldmann

Blood· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.
Zhihui Song, Wenjun Wu, Wei Wei, Wenming Xiao, Michelle Lei, Thomas A Waldmann

Blood· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.
Jonathan E Brammer, Karen Ballen, Lubomir Sokol, Christiane Querfeld, Ryotaro Nakamura, Thomas A Waldmann

Blood· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accessory cells precondition naïve T cells and regulatory T cells for cytokine-mediated proliferation.
Noriko Sato, Richard N Bamford, Bonita R Bryant, Yutaka Tagaya, Thomas A Waldmann

Proc Natl Acad Sci U S A· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies.
Milos D Miljkovic, Sigrid P Dubois, Jürgen R Müller, Bonita Bryant, Elaine Ma, Thomas A Waldmann

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
Masahiro Chiba, Joji Shimono, Takashi Ishio, Norio Takei, Kohei Kasahara, Thomas A Waldmann

Blood· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The implications of IL-15 trans-presentation on the immune response.
Thomas A Waldmann, Robert Waldmann, Jian-Xin Lin, Warren J Leonard

Adv Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL15 and Anti-PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors.
Wei Chen, Richard N Bamford, Elijah F Edmondson, Thomas A Waldmann

Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.
Anusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, Shyh-Ming Yang, Philip Homan, Thomas A Waldmann

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Takashi Ishio, Sarvesh Kumar, Joji Shimono, Anusara Daenthanasanmak, Sigrid Dubois, Thomas A Waldmann

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A very long-acting IL-15: implications for the immunotherapy of cancer.
John A Hangasky, Wei Chen, Sigrid P Dubois, Anusara Daenthanasanmak, Jürgen R Müller, Thomas A Waldmann

J Immunother Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 -Presentation Is an Autonomous, Antigen-Independent Process.
Ádám Kenesei, Julianna Volkó, Nikoletta Szalóki, Gábor Mocsár, Károly Jambrovics, Thomas A Waldmann

J Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.
Kevin Conlon, Dionysios C Watson, Thomas A Waldmann, Antonio Valentin, Cristina Bergamaschi

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.
Javier Traba, Michael N Sack, Thomas A Waldmann, Olga M Anton

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGR1 Addiction in Diffuse Large B-cell Lymphoma.
Shuichi Kimpara, Li Lu, Nguyet M Hoang, Fen Zhu, Paul D Bates, Thomas A Waldmann

Mol Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphomas in Mice.
Sigrid Dubois, Thomas A Waldmann, Jürgen R Müller

J Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma.
Hongbo Wang, Wei Wei, Jing-Ping Zhang, Zhihui Song, Yangyang Li, Thomas A Waldmann

Leukemia· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases.
Marcia Bellon, Izabela Bialuk, Veronica Galli, Xue-Tao Bai, Lourdes Farre, Thomas A Waldmann

Mol Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies.
Sigrid P Dubois, Milos D Miljkovic, Thomas A Fleisher, Stefania Pittaluga, Jennifer Hsu-Albert, Thomas A Waldmann

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-κB-induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia.
Yunlong He, Nagesh Pasupala, Huijun Zhi, Batsuhk Dorjbal, Imran Hussain, Thomas A Waldmann

Proc Natl Acad Sci U S A· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia.
Anusara Daenthanasanmak, Yuquan Lin, Meili Zhang, Bonita R Bryant, Michael N Petrus, Thomas A Waldmann

Transl Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma.
Zhihui Song, Wei Wei, Wenming Xiao, Essel D Al-Saleem, Reza Nejati, Thomas A Waldmann

Proc Natl Acad Sci U S A· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis